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http://dx.doi.org/10.1016/j.cell.2015.04.021DNA N6-methyladenine (6mA) protects against restriction enzymes in bacteria. However, isolated
reports have suggested additional activities and its presence in other organisms, such as unicellular
eukaryotes. New data now find that 6mA may have a gene regulatory function in green alga, worm,
and fly, suggesting m6A as a potential ‘‘epigenetic’’ mark.The Origins of Adenine Methylation
Genetic constraints hamper the response of cells to the changing
environment and represent a hurdle to adaptations that charac-
terize living organisms. Thus, dynamic modifications that expand
thegenetic codebeyondA,G,C, andT are necessary. Among the
most studied, 5-methylcytosine (5mC) exerts a predominant role
due to its important activities in mammals to establish the epige-
netic setting and its relevance in human disorders, particularly
cancer (Heyn and Esteller, 2012). 5mC has been named the fifth
base of DNA, and only lately has a second modification in DNA,
5-hydromethylcytosine (5hmC), emerged as a contender for
human cells (Kohli and Zhang, 2013). Other derivatives, such as
5-formylcytosine and 5-carboxylcytosine, are so far considered
transitory byproducts of oxidative demethylation (Kohli and
Zhang, 2013). However, this can be an anthropocentric view.
N4-methylcytosine (4mC) is very common in bacteria but absent
in mammals. There is an even more intriguing DNA modification:
N6-methyladenine (6mA) (Figure 1A).
6mA represents a dominant modification in bacteria, while
5mC is absent in many prokaryotic genomes (Fang et al.,
2012). In bacteria, 6mAwas initially reported to be part of restric-
tion-modification (R-M) systems—bacterial defense mecha-
nisms against phages and plasmids that are able to distinguish
between host and invader DNA (Arber and Dussoix, 1962).
Specifically, the presence of 6mA in the host prevents the diges-
tion of its genome by DNA methylation-sensitive restriction
enzymes. In contrast, foreign unmethylated DNA lacks the pro-
tection and is readily degradedwhen entering the cells. R-M sys-
tem-positive strains are equipped with DNA methyl-transferase
and endonuclease counterparts with common sequence recog-
nition motifs.
However, the fact that other methyl-transferases lack a
restriction enzyme counterpart and that m6A is important
for viability in specific bacterial strains suggests a defense-in-
dependent function. Specifically, adenine methylation is estab-
lished as a bacterial epigenetic mark. Exemplary, solitary
adenine methylases, such as Dam in E. coli, are involved in
DNA replication, wherein sister-strand synthesis can only be710 Cell 161, May 7, 2015 ª2015 Elsevier Inc.initiated in the presence of methylated adenine at replication
origin (Wion and Casadesu´s, 2006). Dam-mediated methylation
also regulates replication initiator factors.
6mA guides the discrimination between original and newly
synthesized DNA strand after replication. As de novo adenine
methylation is delayed during the cell cycle, the newly synthe-
sized strand is recognized by repair enzymes and the Dammotif
enables endonuclease processing with subsequent repair pro-
cesses (Wion and Casadesu´s, 2006). Adenine methylation has
further functional implication in the cell cycle, repression of
transposable elements, and gene regulatory processes (Fang
et al., 2012). 6mA also reduces the stability of base pairings,
hence favoring transcriptional initiation by lowering the energy
to open DNA duplexes. Dam activity can be hindered by binding
of competing proteins, resulting in the formation of non-methyl-
ated sites. Strikingly, the protection from methylation is an in-
herited state that, however, can be modified by environmental
conditions (Wion and Casadesu´s, 2006). Thus, adenine methyl-
ation displays similar characteristics in prokaryotes as cytosine
methylation does in eukaryotes, further underscoring its impor-
tance throughout generations.
Adenine Methylation: An Evolutionary Conserved
Mechanism
Although some studies hypothesized the presence of 6mA
in eukaryotic genomesdecadesago, its implication in epigenetics
in eukaryotes remains elusive (Ratel et al., 2006).Compared to the
highly abundant 5mC in the eukaryotic kingdom, levels of 6mA
were suggested to be minimal and thus only detectable by highly
sensitive technologies.Nevertheless, several studies reported the
presence of 6mA in eukaryotic genomes, particularly in ciliates,
chlorophyte algae, and dinoflagellates (Achwal et al., 1983; Gom-
mers-Ampt and Borst, 1995; Ratel et al., 2006). In certain cases,
6mA exists in substantial amounts, with 0.5%–10% of adenines
being methylated.
Sequence analysis predicted the presence of adenine methyl-
transferases and demethylases in several eukaryotic organisms
(Iyer et al., 2011) (Figure 1A). The presence of methyl-transferase
Figure 1. Processing and Detection of
N6-Methyladenine
(A) Adenine bases of DNA are modified by
N6-methyladenine (6mA) methyl-transferases
and 6mA demethylases. The modifying enzymes
are conserved in all super-kingdoms of life, with
putative activity also in Homo sapiens (TET1–3
proteins have so far proven activities as 5mC
oxidases).
(B) Methyladenine is detectable by chromatog-
raphy-based technologies, such as the ultra-
high performance liquid chromatography-triple
quadrupole mass spectrometry coupled with
multiple-reaction monitoring (UHPLC-MRM-MS/
MS) method or sequencing approaches. For
the specific quantification of methyladenine, next-
generation sequencing (NGS)-based strategies
are coupled with immunoprecipitation of 6mA
(6mA-IPseq) or restriction enzyme guidance
(6mA-REseq). Direct quantification at base-pair
resolution is enabled by third-generation seq-
uencing methods, such as the single-molecule
real-time (SMRT) technology, wherein variant
enzyme kinetics identify modified DNA bases.orthologswithin transposable elements led to the hypothesis of a
cis-acting control mechanism to secure host genome integrity.
Consistently, such a mechanism was identified in E. coli, sug-
gesting a conserved function of 6mA as safeguard of the genome
(Roberts et al., 1985).
Now, three studies in this issue of Cell report the presence of
6mA in three different eukaryotic genomes—Chlamydomonas
reinhardtii, Caenorhabditis elegans, and Drosophila mela-
nogaster—with putative epigenetic function (Zhang et al.,
2015; Greer et al., 2015; Fu et al., 2015). The authors present ev-
idence for spatiotemporal-regulated 6mA modifications during
development. Moreover, 6mA is associated to gene regulatory
events.
The green alga C. reinhardtii has long been reported to harbor
substantial levels of 6mA, but its spatial distribution and functionCelhad yet to be identified (Hattman et al.,
1978). Using sequencing-based mapping
strategies, Fu et al. produce the first
genome-wide reference map for methyla-
denine in C. reinhardtii (Fu et al., 2015).
Moreover, the authors provide evidence
for an epigenetic function in transcrip-
tional regulation. After confirming abun-
dant 6mA levels by highly sensitive
liquid-chromatography and mass-spec-
trometry methodologies (Figure 1B), they
show that 6mA levels are stable and in-
herited duringmultiple replication phases.
Immunoprecipitation-based sequencing
strategies (Figure 1B) identify sequence
motifs susceptible to undergo adenine
methylation, which are different from the
prokaryotic consensus sequences. Sub-
sequently, restriction enzyme-guided re-
sequencing produces a 6mA reference
methylome of C. reinhardtii at base-pairresolution (Figure 1B). Intriguingly, although the methyl-trans-
ferase consensus sequence is equally distributed in the genome,
6mA ishighly enrichedat genepromotersbutdepletedat the tran-
scription start sites. Consistently, 6mA profiles reveal periodic
patterns of 130–140 bp distances and hence a potential associa-
tion tonucleosomepositioningatpromoter regions. Thepresence
of 6mA at gene promoters is positively correlated with increased
transcriptional activity.
While adenine methylation has been previously described
in C. reinhardtii, its presence in 6mA C. elegans has not been re-
ported despite the presence of putatively active methyl-transfer-
ases in the worm genome. Greer et al. now report 6mA to be
present in C. elegans and functionally involved in epigenetic
transgenerational inheritance (Greer et al., 2015). In C. elegans,
mutants lacking histone demethylase spr-5, responsible forl 161, May 7, 2015 ª2015 Elsevier Inc. 711
dimethylation of the histone H3 at lysine 4, represent a paradigm
of inheritance. Although no phenotype is detectable in early
generations, the mutant worms become progressively infertile
in later generations, accompanied by increasing histone H3
methylation levels. Surprisingly, Greer et al. now describe that
spr-5mutants reveal elevated levels of 6mA, accumulating during
generations. 6mA inC.elegans is shown tobeaddedby the newly
identified DNA N6-adenine methyl-transferase 1 (DAMT-1) and
dynamically removed by the N6-methyladenine demethylase 1
(NMAD-1). Strikingly, mutations in NMAD-1 lead to accelerated
accumulation of 6mA and, moreover, speed up the sterility
phenotype in nmad-1 and spr-5 double-knockout worms.
Overall, 6mA in C. elegans is rather low in wild-type animals
(0.025%) but is increased 10-fold in spr-5 mutant animals. It is
noteworthy that, unlike in flies (see below), adenine methylation
in C. elegans is ubiquitously present in all cell types. Technically,
6mA is determined by different technologies, ranging from global
to base-pair resolution profiles using single-molecule real-time
(SMRT) sequencing (Figure 1B). Particularly, the latter approach
leads to the identification of specific sequence motifs, suggest-
ing a locally regulated deposition of 6mA. However, its functional
role remains elusive. Future functional genomics approaches,
including a systematic integration of transcriptional profiles,
are needed.
The absence of conclusive evidence for cytosine or adenine
methylation in D. melanogaster has led to the hypothesis that
gene regulation takes place without DNA modifications. How-
ever, as 6mA is present in eukaryotes at very low levels, Zhang
et al. speculate that an impaired function of the putative DNA de-
methylase DMAD (DNA 6mA demethylase) leads to detectable
6mA inD. melanogaster (Zhang et al., 2015). Indeed, using highly
sensitive methods (Figure 1B), the authors identify adenine
methylation, predominantly in very early developmental stages
of the fly embryos (0.07%), but also in somatic cell types.
The late-embryo extracts also exhibit elevated demethylating
activity compared with early stages.
Demethylation dynamics could be associated with the TET-
like protein DMAD, which is dynamically regulated during devel-
opment. Moreover, DMAD modifies 6mA levels in vitro and
in vivo, and altered demethylase activity leads to increased em-
bryo lethality. 6mA is also detectable in somatic tissue, particu-
larly in ovary and brain cells. Here, 6mA is restricted to certain
cell types, being highly abundant in germarium cells while losing
intensities during germ cell differentiation. In line with these
results, DMAD levels increase during egg differentiation, and
DMAD mutants present elevated 6mA levels in their ovaries,
accompanied by a higher number of undifferentiated cells.
Furthermore, high levels of DMAD in brain suggest an antago-
nistic function in methyl-transferase activities and a dominant
suppression of 6mA levels in neurons. 6mA is determined to be
enriched in transposon gene bodies, with a putative function in
transcriptional activation during early embryonic stages and in
undifferentiated cell types.
From the current 6mA knowledge, C. elegans and
D. melanogaster do not present methylcytosine in their ge-
nomes. Although the existence of 5mC in Drosophila was under
controversial discussion for years, recent studies using whole-
genome bisulfite sequencing mostly excluded the presence of712 Cell 161, May 7, 2015 ª2015 Elsevier Inc.5mC in D. melanogaster DNA sequence (Raddatz et al., 2013).
Hence, the studies by Greer et al. and Zhang et al. suggest
6mA as the unique DNAmethylation modification and potentially
functional epigenetic mark in C. elegans and D. melanogaster,
respectively. Although the global levels of 6mA are rather low,
its local enrichment and sequence specificity point to regulated
processing throughout development and differentiation. Future
studies need to further establish its role as epigenetic mark
and its function in gene regulation.
However, 6mA and 5mC have been described to co-exist
in the C. reinhardtii genome. Consistently, methyl-transferases
and demethylases are conserved in the green alga (Iyer et al.,
2011) (Figure 1A). Now, base-pair resolution landscapes of
both DNA modifications in C. reinhardtii reveal a likely com-
plementary function of 6mA and 5mC, indicated by their spatial
separation in the genome (Fu et al., 2015). While 5mC is enriched
at the gene bodies of lowly expressed transcripts, 6mA accumu-
lates at the promoter region of highly active genes. It is remark-
able that 5mC in Chlamydomonas exists at lower levels than
observed in higher eukaryotes and is not restricted to CpGmotifs
(Feng et al., 2010). Taken together, the evidence suggests 6mA
to represent an active epigenetic mark in C. reinhardtii, while
5mC is likely to be involved in processes downstream of tran-
scriptional initiation.
Intriguingly, although cytosine methylation represents by far
the dominant DNA modification in Homo sapiens, the machinery
to modify adenine nucleotides is conserved during evolution.
In this regard, the methyl-transferase-like 4 (METTL4) is similar
to DAMT-1 in C. elegans (Greer et al., 2015) (Figure 1A). More-
over, active demethylases of the TET family proteins, such as
DMAD in D. melanosgaster, exhibit specificity for methyl
adenines and thus might also be implicated in 6mA dynamics
in higher eukaryotes (Iyer et al., 2011). In this regard, early studies
also reported 6mA in human tissue, specifically placenta (Achwal
et al., 1983). However, the presence and function of the adenine
code in mammals need to be confirmed by applying novel ultra-
sensitive detection technologies (Figure 1B). These technologies
will play a key role in improving our understanding on the
complexity of DNA modifications in the biology of eukaryotic
life and will be discussed below.
The detection of 6mA in human placenta encourages specula-
tions of a specialized function of adenine methylation in specific
cell types. Taking into account the mutagenic nature of 5mC,
continuously dividing cell types, such as adult stem cells, might
have conserved an epigenetic mechanism that better supports
the integrity of the DNA template. 6mA presents a potential alter-
native to 5mC to avoid the accumulation of de novo mutations in
the immortal DNA strand. In line, 6mA is determined to be highly
abundant in early stages of development and undifferentiated
reproductive tissue in D. melanogaster, supporting the hypothe-
sis of an epigenetic mark with restricted function in pluripotent
cell types (Zhang et al., 2015).
Sensitive Detection of Adenine Methylation of DNA
Many of the questions that we have now for 6mA remained open
not so long ago for 5mC and 5hmC. For these two cases, the
development of bisulfite sequencing and other genome-scale
analyses has provided many of the requested answers. Though
the same user-friendly powerful technologies does not exist for
6mA, there are already promising tools to entangle the presence
and role of this enigmatic modification in eukaryotes (Figure 1B).
Let’s briefly summarize them.
Ultra-High Performance Liquid Chromatography-Triple
Quadrupole Mass Spectrometry
This approach allows the sensitive detection of nucleotide mod-
ifications, such as 5mC and 6mA, at very low abundance (Ito
et al., 2011). Briefly, the digested DNA is separated by reverse-
phase ultra-high performance liquid chromatography (UHPLC)
coupled with mass spectrometry detection using tandem mass
spectrometers (MS/MS). Following detection of specific nucleo-
tide modifications, quantification is achieved using a standard
curve that is simultaneously analyzed in the sample of interest.
It is important to discard any potential contamination fromMyco-
plasma or bacterial DNA.
6mA-Immunoprecipitation Sequencing
Immunoprecipitation coupled with next-generation sequencing
was previously established for 5mC detection in mammalian
genomes (Weber et al., 2005). 6mA-immunoprecipitatoin seq-
uencing (6mA-IPseq) utilizes a specific antibody for methylade-
nine to enrich modified fragments from the sequencing library.
Following the alignment of sequencing reads to the reference
genome, 6mA-modified regions present enriched mapping fre-
quencies. 6mA-IPseq allows charting the spatial distribution of
the epigenetic mark. Subsequent sequence enrichment analysis
can also point to consensus recognition motifs for the adenine
methyl-transferases.
Restriction Enzyme-Based 6mA Sequencing
Restriction enzyme-based 6mA sequencing (6mA-REseq) relies
on the determination of consensus target sequences of adenine
methylation, followed by the identification of restriction enzymes
with respective recognition sites and sensitivity for the DNA
modification (Fu et al., 2015). Technically, genomic DNA is frag-
mented with a 6mA-sensitive enzyme, followed by random
shearing of the template. It results in an enrichment of unmethy-
lated (digested) sequence motifs at the ends of the sequencing
reads. Conversely, methylated adenine prevents digestion and
is enriched in inner fractions of the reads. Consequently, 6mA
levels are readily inferred from the relative position of the restric-
tion enzyme consensus sequence.
Single-Molecule Real-Time Sequencing
Initial genome-wide methyladenine maps at base-pair resolution
were obtained in E. coli genomes using single-molecule real-
time (SMRT) sequencing (Clark et al., 2012; Fang et al., 2012;
Murray et al., 2012). SMRT, a third-generation sequencing
technique, is based on the processing of fluorescence-labeled
nucleotides by DNA polymerases. The fluorescence label is not
incorporated in the de novo synthesized strand but is cleaved
away during the process. Meanwhile, the label emits light that
is captured in the nanophotonic visualization chamber. High-fi-
delity polymerases are capable of synthesizing long continuous
strands at a high speed, allowing a fast sequencing process and
high read lengths. Importantly, the incorporation of a modified
nucleotide, such as 6mA, presents different kinetics compared
with unmodified adenine, allowing the direct inference of the
modification status of each base.Conclusions
m6A is a covalent modification of DNA that exerts an essential
role in bacteria, where it is associated with genome protection
via R-M systems. Furthermore, formation of m6A plays roles
in bacterial DNA replication, mismatch repair, and gene tran-
scription. Its presence in the genomes of several eukaryotes
reinforces the notion that m6A is widespread and suggests its
still unknown activities. The accompanying articles in this issue
of Cell describe a transcriptional regulatory role for m6A in
Chlamydomonas, and its detection, although at low levels, in
D. melanogaster and C. elegans indicates an expanded function
for 6mA. The development of improved technologies to unam-
biguously quantify and characterize 6mA in different biological
contexts will be a necessary step in this exciting journey.REFERENCES
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